Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?-Reference-Cited by-同舟云学术

Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

Published:2017-02-14 Issue: Volume:9 Page:
ISSN:1663-4365
Container-title:Frontiers in Aging Neuroscience
language:
Short-container-title:Front. Aging Neurosci.

Author:

Männistö Pekka T.,García-Horsman J. Arturo

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Ageing

Reference101 articles.

1. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues;Agirregoitia;Regul. Pept.,2007

2. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: a rebuttal;Agustí-Cobos;J. Thromb. Haemost.,2011

3. Prolyl endopeptidase cleaves the apoptosis rescue peptide humanin and exhibits an unknown post-cysteine cleavage specificity;Bar;Adv. Exp. Med. Biol.,2006

4. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α-melanocyte-stimulating hormone breakdown in the rat brain;Bellemère;J. Neurochem.,2003

5. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain;Bellemère;J. Neuroendocrinol.,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics;Ageing Research Reviews;2024-11

2. Missense variants in CMS22 patients reveal that PREPL has both enzymatic and nonenzymatic functions;JCI Insight;2024-09-10

3. Indole-based thiosemicarbazones for neurodegenerative diseases as prolyl oligopeptidase inhibitors;Journal of Molecular Structure;2024-09

4. The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation;Heliyon;2024-07

5. Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review;Results in Chemistry;2024-01